Genomic, Marker-Assisted, and Pedigree-BLUP Selection Methods for β-Glucan Concentration in Elite Oat

β-glucan, a soluble fiber found in oat (Avena sativa L.) grain, is good for human health, and selection for higher levels of this compound is regarded as an important breeding objective. Recent advances in oat DNA markers present an opportunity to investigate new selection methods for polygenic traits such as β-glucan concentration. Our objectives in this study were to compare genomic, marker-assisted, and best linear unbiased prediction (BLUP)–based phenotypic selection for short-term response to selection and ability to maintain genetic variance for β-glucan concentration. Starting with a collection of 446 elite oat lines from North America, each method was conducted for two cycles. The average β-glucan concentration increased from 4.57 g/100 g in Cycle 0 to between 6.66 and 6.88 g/100 g over the two cycles. The averages of marker-based selection methods in Cycle 2 were greater than those of phenotypic selection (P \u3c 0.08). Progenies with the highest β-glucan came from the marker-based selection methods. Marker-assisted selection (MAS) for higher β-glucan concentration resulted in a later heading date. We also found that marker-based selection methods maintained greater genetic variance than did BLUP phenotypic selection, potentially enabling greater future selection gains. Overall, the results of these experiments suggest that genomic selection is a superior method for selecting a polygenic complex trait like β-glucan concentration

Abdômen agudo em equídeos no semiárido da região nordeste do Brasil

Foram revisados os casos de abdômen agudo de origem gastrintestinal em equídeos atendidos no Hospital Veterinário da Universidade Federal de Campina Grande, em Patos, Paraíba. No período de janeiro de 2001 a dezembro de 2010. Setenta (4,5%) do total de 1542 equídeos atendidos no período apresentaram quadro clínico de cólica, sendo 60 equinos, cinco muares e cinco asininos. A compactação de cólon maior foi a causa mais frequente de cólica, diagnosticada em 37,14% dos casos, seguida por compactação de cólon menor (10%) e corpo estranho de cólon menor (7,14%). Em quatro casos as cólicas foram causadas pela presença de fitobezoares no intestino grosso, sendo dois deles associados ao consumo de vagens de Prosopis juliflora. Em cinco casos foi observada a presença de corpos estranhos no cólon menor e em um caso os corposestranhos foram encontrados no cólon maior, sendo principalmente sacos plásticos. As lesões estrangulantes do intestino delgado foram observadas em quatro casos. Outras causas foram cólica espasmódica (dois casos por parasitose e dois por ingestão de resíduos domiciliares), sobrecarga gástrica (três casos) e deslocamento de cólon maior que foi diagnosticado em dois animais. Laceração de cólon menor, torção de ceco, compactação de ceco e timpanismo por consumo de Manihot esculenta foram diagnosticados em uma única ocasião. O principal fator de risco para o desenvolvimento de cólicas foi o consumo de Pennisetum purpureum, Brachiaria decumbens, Sorghum spp. ou Echinochloa polystachya picados manualmente ou em picotadeira ou triturados em forrageira (OR=4,03; P=0,007). Como resultado da baixa qualidade dos alimentos ingeridos, a frequência dos atendimentos de equídeos portadores de cólica foi significativamente maior no segundo semestre (época da seca na região estudada) (OR=2,61; P<0,01). Concluiu-se que a oferta de volumoso de baixa qualidade na seca contribui para a alta frequência de casos de cólica e que o manejo alimentar tem um papel importante na ocorrência da doença e, por isso, a sua melhoria pode influenciar positivamente na redução do número de casos de cólica em equídeos no semiárido nordestino

Regions of the genome that affect agronomic performance in two-row barley

Quantitative trait locus (QTL) main effects and QTL by environment (QTL × E) interactions for seven agronomic traits (grain yield, days to heading, days to maturity, plant height, lodging severity, kernel weight, and test weight) were investigated in a two-row barley (Hordeum vulgare L.) cross, Harrington/TR306. A 127-point base map was constructed from markers (mostly RFLP) scored in 146 random double-haploid (DH) lines from the Harrington/TR306 cross. Field experiments involving the two parents and 145 random DH lines were grown in 1992 and/or 1993 at 17 locations in North America. Analysis of QTL was based on simple and composite interval mapping. Primary QTL were declared at positions where both methods gave evidence for QTL. The number of primary QTL ranged from three to six per trait, collectively explaining 34 to 52% of the genetic variance. None of these primary QTL showed major effects, but many showed effects that were consistent across environments. The addition of secondary QTL gave models that explained 39 to 80% of the genetic variance. The QTL were dispersed throughout the barley genome and some were detected in regions where QTL have been found in previous studies. Eight chromosome regions contained pleiotropic loci and/or linked clusters of loci that affected multiple traits. One region on chromosome 7 affected all traits except days to heading. This study was an intensive effort to evaluate QTL in a narrow-base population grown in a large set of environments. The results reveal the types and distributions of QTL effects manipulated by plant breeders and provide opportunities for future testing of marker-assisted selection

Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury

A proportion of patients infected with severe acute respiratory syndrome coronavirus 2 experience a range of neuropsychiatric symptoms months after infection, including cognitive deficits, depression and anxiety. The mechanisms underpinning such symptoms remain elusive. Recent research has demonstrated that nervous system injury can occur during COVID-19. Whether ongoing neural injury in the months after COVID-19 accounts for the ongoing or emergent neuropsychiatric symptoms is unclear. Within a large prospective cohort study of adult survivors who were hospitalized for severe acute respiratory syndrome coronavirus 2 infection, we analysed plasma markers of nervous system injury and astrocytic activation, measured 6 months post-infection: neurofilament light, glial fibrillary acidic protein and total tau protein. We assessed whether these markers were associated with the severity of the acute COVID-19 illness and with post-acute neuropsychiatric symptoms (as measured by the Patient Health Questionnaire for depression, the General Anxiety Disorder assessment for anxiety, the Montreal Cognitive Assessment for objective cognitive deficit and the cognitive items of the Patient Symptom Questionnaire for subjective cognitive deficit) at 6 months and 1 year post-hospital discharge from COVID-19. No robust associations were found between markers of nervous system injury and severity of acute COVID-19 (except for an association of small effect size between duration of admission and neurofilament light) nor with post-acute neuropsychiatric symptoms. These results suggest that ongoing neuropsychiatric symptoms are not due to ongoing neural injury

Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study

Background People hospitalised for coronavirus disease 2019 (COVID-19) have elevated incidence of diabetes. However, it is unclear whether this is due to shared risk factors, confounding or stress hyperglycaemia in response to acute illness. Methods We analysed a multicentre prospective cohort study (PHOSP-COVID) of people ≥18 years discharged from NHS hospitals across the United Kingdom following COVID-19. Individuals were included if they attended at least one research visit with a HbA1c measurement within 14 months of discharge and had no history of diabetes at baseline. The primary outcome was new onset diabetes (any type), as defined by a first glycated haemoglobin (HbA1c) measurement ≥6.5% (≥48 mmol/mol). Follow-up was censored at the last HbA1c measurement. Age-standardised incidence rates and incidence rate ratios (adjusted for age, sex, ethnicity, length of hospital stay, body mass index, smoking, physical activity, deprivation, hypertension, hyperlipidaemia/hypercholesterolaemia, intensive therapy unit admission, invasive mechanical ventilation, corticosteroid use and C-reactive protein score) were calculated using Poisson regression. Incidence rates were compared with the control groups of published clinical trials in the United Kingdom by applying the same inclusion and exclusion criteria, where possible. Results Incidence of diabetes was 91.4 per 1000 person-years and was higher in South Asian (incidence rate ratios [IRR] = 3.60; 1.77, 7.32; p < 0.001) and Black ethnic groups (IRR = 2.36; 1.07, 5.21; p = 0.03) compared with White ethnic groups. When restricted to similar characteristics, the incidence rates were similar to those in UK clinical trials data. Conclusion Diabetes incidence following hospitalisation for COVID-19 is high, but it remains uncertain whether it is disproportionately higher than pre-pandemic levels

Long COVID and cardiovascular disease: a prospective cohort study

Background Pre-existing cardiovascular disease (CVD) or cardiovascular risk factors have been associated with an increased risk of complications following hospitalisation with COVID-19, but their impact on the rate of recovery following discharge is not known. Objectives To determine whether the rate of patient-perceived recovery following hospitalisation with COVID-19 was affected by the presence of CVD or cardiovascular risk factors. Methods In a multicentre prospective cohort study, patients were recruited following discharge from the hospital with COVID-19 undertaking two comprehensive assessments at 5 months and 12 months. Patients were stratified by the presence of either CVD or cardiovascular risk factors prior to hospitalisation with COVID-19 and compared with controls with neither. Full recovery was determined by the response to a patient-perceived evaluation of full recovery from COVID-19 in the context of physical, physiological and cognitive determinants of health. Results From a total population of 2545 patients (38.8% women), 472 (18.5%) and 1355 (53.2%) had CVD or cardiovascular risk factors, respectively. Compared with controls (n=718), patients with CVD and cardiovascular risk factors were older and more likely to have had severe COVID-19. Full recovery was significantly lower at 12 months in patients with CVD (adjusted OR (aOR) 0.62, 95% CI 0.43 to 0.89) and cardiovascular risk factors (aOR 0.66, 95% CI 0.50 to 0.86). Conclusion Patients with CVD or cardiovascular risk factors had a delayed recovery at 12 months following hospitalisation with COVID-19. Targeted interventions to reduce the impact of COVID-19 in patients with cardiovascular disease remain an unmet need